AbbVie
ABBV
#25
Rank
โ‚ฌ459.14 B
Marketcap
259,75ย โ‚ฌ
Share price
-2.33%
Change (1 day)
28.63%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): 5,11ย โ‚ฌ

According to AbbVie's latest financial reports the company's current EPS (TTM) is 5,31ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 2,15ย โ‚ฌ a decrease over its 2024 EPS that were of 2,20ย โ‚ฌ.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)5,11ย โ‚ฌ137.8%
20252,15ย โ‚ฌ-2.26%
20242,20ย โ‚ฌ-11.86%
20232,50ย โ‚ฌ-58.95%
20226,08ย โ‚ฌ2.49%
20215,93ย โ‚ฌ121.58%
20202,68ย โ‚ฌ-44.7%
20194,84ย โ‚ฌ45.84%
20183,32ย โ‚ฌ9.72%
20173,03ย โ‚ฌ-9.54%
20163,34ย โ‚ฌ16.28%
20152,88ย โ‚ฌ184.1%
20141,01ย โ‚ฌ-57.15%
20132,36ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,64ย โ‚ฌ-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
28,06ย โ‚ฌ 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,78ย โ‚ฌ 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2,14ย โ‚ฌ-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,82ย โ‚ฌ-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,11ย โ‚ฌ-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6,47ย โ‚ฌ 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2,61ย โ‚ฌ-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
6,33ย โ‚ฌ 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA